These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2964160

  • 1. [Human atrial natriuretic factor (hANF) in liver cirrhosis].
    Pidlich J, Müller C, Hartter E, Renner F, Klepetko W, Miholic J, Woloszczuk W.
    Acta Med Austriaca; 1987; 14(5):125-9. PubMed ID: 2964160
    [Abstract] [Full Text] [Related]

  • 2. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [Abstract] [Full Text] [Related]

  • 3. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
    Chen YX, Wang SC, Zhao GN, Tang J, Zhang SX, Tang CS.
    Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
    [Abstract] [Full Text] [Related]

  • 4. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V, Zjacic-Rotkvic V, Marout J, Sefer S, Troskot B.
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [Abstract] [Full Text] [Related]

  • 5. Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation.
    Klepetko W, Müller C, Hartter E, Miholics J, Schwarz C, Woloszczuk W, Moeschl P.
    Gastroenterology; 1988 Sep; 95(3):764-70. PubMed ID: 2969346
    [Abstract] [Full Text] [Related]

  • 6. [ANP in the cirrhotic patient. A clinical contribution].
    Parlapiano C, Labellarte A, Primi F, Cervellini P, La Torre F, Paparo SB, Baccarini S, Di Nardo A.
    Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
    [Abstract] [Full Text] [Related]

  • 7. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL, Arendt R, Xie Y, Knorr HJ, Riedel A, Paumgartner G.
    Z Kardiol; 1988 Sep; 77 Suppl 2():99-103. PubMed ID: 2970181
    [Abstract] [Full Text] [Related]

  • 8. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
    Jiménez W, Gutkowska J, Ginés P, Arroyo V, Rivera F, Rodés J.
    Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302
    [Abstract] [Full Text] [Related]

  • 9. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
    Bonkovsky HL, Hartle DK, Mellen BG, Kutner M, Galambos JT.
    Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
    Akriviadis EA, Ervin MG, Cominelli F, Fisher DA, Reynolds TB.
    Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
    [Abstract] [Full Text] [Related]

  • 15. [Reaction of the cardiovascular and humoral system to acute hypervolemia in patients with liver cirrhosis].
    Kozáková M, Tesar V, Petrtýl J, Horký K, Kordac V.
    Cas Lek Cesk; 1989 Feb 03; 128(6):168-73. PubMed ID: 2524257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
    Ferrier C, Beretta-Piccoli C, Weidmann P, Gnädinger MP, Shaw S, Suchecka-Rachon K, Saxenhofer H.
    Am J Nephrol; 1989 Feb 03; 9(4):291-9. PubMed ID: 2530903
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W, Liu P, Blendis L, Wong F.
    Am J Med; 1999 Mar 03; 106(3):315-22. PubMed ID: 10190381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.